Aggresome-related biogenesis of Lewy bodies

European Journal of Neuroscience

Volumn 16, Issue 11, 2002, Pages 2136-2148

  McNaught, Kevin St P ^a   Shashidharan, P ^a   Perl, Daniel P ^a   Jenner, Peter ^b   Olanow, C Warren ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

synuclein; tubulin; Centrosome; Parkinson's disease; Proteasome

Indexed keywords

CELL PROTEIN; GAMMA TUBULIN; HEAT SHOCK PROTEIN 70; PERICENTRIN; PROTEASOME; PROTEIN ANTIBODY; PROTEIN PA28; PROTEIN PA700; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; CELL INCLUSION; CELLULAR DISTRIBUTION; CENTROSOME; CLINICAL ARTICLE; CONJUGATE; CONTROLLED STUDY; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN TISSUE; LEWY BODY; NERVE CELL CULTURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN LOCALIZATION;

ACETYLCYSTEINE; ANTIGENS; BRAIN; CANAVANINE; CENTROSOME; DOSE-RESPONSE RELATIONSHIP, DRUG; GOLGI APPARATUS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODIES; LEWY BODY DISEASE; NERVE TISSUE PROTEINS; NEURONS; PARKINSON DISEASE; PEPTIDE HYDROLASES; PROTEIN FOLDING; SYNUCLEINS; TUBULIN; UBIQUITINS;

EID: 0036456584     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2002.02301.x     Document Type: Article

References (63)

1. Alam, Z.I., Daniel, S.E., Lees, A.J., Marsden, D.C., Jenner, P. & Halliwell, B. (1997) A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem., 69, 1326-1329.
2. Auluck, P.K., Chan, E., Trojanowski, J.Q., Lee, V. & Bonini, N.M. (2002) Chaperone suppression of alpha-synuclein toxicity in a drosophila model of Parkinson's disease. Science, 295, 865-868.
3. Baas, P.W. (1999) Microtubules and neuronal polarity: Lessons from mitosis. Neuron, 22, 23-31.
4. Bence, N.F., Sampat, R.M. & Kopito, R.R. (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science, 292, 1552-1555.
5. Chung, K.K., Zhang, Y., Lim, K.L., Tanaka, Y., Huang, H., Gao, J., Ross, C.A., Dawson, V.L. & Dawson, T.M. (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: Implications for Lewy-body formation in Parkinson disease. Nature Med., 7, 1144-1150.
6. Doxsey, S.J., Stein, P., Evans, L., Calarco, P.D. & Kirschner, M. (1994) Pericentrin, a highly conserved centrosome protein involved in microtubule organization. Cell, 76, 639-650.
7. van Duinen, S.G., Lammers, G.J., Maat-Schieman, M.L. & Roos, R.A. (1999) Numerous and widespread alpha-synuclein-negative Lewy bodies in an asymptomatic patient. Acta Neuropathol. (Berl.), 97, 533-539.
8. El-Khodor, B.F., Kholodilov, N.G., Yarygina, O. & Burke, R.E. (2001) The expression of mRNAs for the proteasome complex is developmentally regulated in the rat mesencephalon. Brain Res. Dev. Brain Res., 129, 47-56.
9. Fabunmi, R.P., Wigley, W.C., Thomas, P.J. & DeMartino, G.N. (2000) Activity and regulation of the centrosome-associated proteasome. J. Biol. Chem., 275, 409-413.
10. Fenteany, G. & Schreiber, S.L. (1998) Lactacystin, proteasome function, and cell fate. J. Biol. Chem., 273, 8545-8548.
11. Fergusson, J., Landon, M., Lowe, J., Dawson, S.P., Layfield, R., Hanger, D.P. & Mayer, R.J. (1996) Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome. Neurosci Lett., 219, 167-170.
12. Floor, E. & Wetzel, M.G. (1998) Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J. Neurochem., 70, 268-275.
13. Forno, L.S. (1996) Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol., 55, 259-272.
14. French, B.A., van Leeuwen, F., Riley, N.E., Yuan, Q.X., Bardag-Gorce, F., Gaal, K., Lue, Y.H., Marceau, N. & French, S.W. (2001) Aggresome formation in liver cells in response to different toxic mechanisms: Role of the ubiquitin-proteasome pathway and the frameshift mutant of ubiquitin. Exp. Mol. Pathol., 71, 241-246.
15. Fujimuro, M., Sawada, H. & Yokosawa, H. (1994) Production and characterization of monoclonal antibodies specific to multi-ubiquitin chains of polyubiquitinated proteins. FEBS Lett., 349, 173-180.
16. Gaczynska, M., Osmulski, P.A. & Ward, W.F. (2001) Caretaker or undertaker? The role of the proteasome in aging. Mech. Ageing Dev., 122, 235-254.
17. Giasson, B.I., Duda, J.E., Murray, I.V., Chen, Q., Souza, J.M., Hurtig, H.I., Ischiropoulos, H., Trojanowski, J.Q. & Lee, V.M. (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science, 290, 985-989.
18. Gibb, W.R. & Lees, A.J. (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry, 51, 745-752.
19. Gomez-Tortosa, E., Newell, K., Irizarry, M.C., Sanders, J.L. & Hyman, B.T. (2000) alpha-Synuclein immunoreactivity in dementia with Lewy bodies: Morphological staging and comparison with ubiquitin immunostaining. Acta Neuropathol. (Berl.), 99, 352-357.
20. Good, P.F., Hsu, A., Werner, P., Perl, D.P. & Olanow, C.W. (1998) Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol., 57, 338-342.
21. Han, S.K., Mytilineou, C. & Cohen, G. (1996) L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress. J. Neurochem., 66, 501-510.
22. Hartl, F.U. & Hayer-Hartl, M. (2002) Molecular chaperones in the cytosol: From nascent chain to folded protein. Science, 295, 1852-1858.
23. Hoffner, G., Kahlem, P. & Djian, P. (2002) Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: Relevance to Huntington's disease. J. Cell Sci., 115, 941-948.
24. Ii, K., Ito, H., Tanaka, K. & Hirano, A. (1997) Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly. J. Neuropathol. Exp. Neurol., 56, 125-131.
25. Jenner, P. & Olanow, C.W. (1998) Understanding cell death in Parkinson's disease. Ann. Neurol., 44, S72-S84.
26. Jensen, P.H., Li, J.Y., Dahlstrom, A. & Dotti, C.G. (1999) Axonal transport of synucleins is mediated by all rate components. Eur. J. Neurosci., 11, 3369-3376.
27. Johnston, J.A., Ward, C.L. & Kopito, R.R. (1998) Aggresomes: A cellular response to misfolded proteins. J. Cell Biol., 143, 1883-1898.
28. Kaytor, M.D. & Warren, S.T. (1999) Aberrant protein deposition and neurological disease. J. Biol. Chem., 274, 37507-37510.
29. Kopito, R.R. (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol., 10, 524-530.
30. Leask, A., Obrietan, K. & Stearns, T. (1997) Synaptically coupled central nervous system neurons lack centrosomal gamma-tubulin. Neurosci. Lett., 229, 17-20.
31. Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M.J., Jonnalagada, S., Chernova, T., Dehejia, A., Lavedan, C., Gasser, T., Steinbach, P.J., Wilkinson, K.D. et al. (1998) The ubiquitin pathway in Parkinson's disease. Nature, 395, 451-452.
32. Lopiano, L., Fasano, M., Giraudo, S., Digilio, G., Koenig, S.H., Torre, E., Bergamasco, B. & Aime, S. (2000) Nuclear magnetic relaxation dispersion profiles of substantia nigra pars compacta in Parkinson's disease patients are consistent with protein aggregation. Neurochem. Int., 37, 331-336.
33. Lowe, J., McDermott, H., Landon, M., Mayer, R.J. & Wilkinson, K.D. (1990) Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J. Pathol., 161, 153-160.
34. Ma, J. & Lindquist, S. (2001) Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc. Natl Acad. Sci. USA, 98, 14955-14960.
35. Masaki, T., Ishiura, S., Sugita, H. & Kwak, S. (1994) Multicatalytic proteinase is associated with characteristic oval structures in cortical Lewy bodies: An immunocytochemical study with light and electron microscopy. J. Neurol. Sci., 122, 127-134.
36. McNaught, K.S., Belezaire, R., Jenner, P., Olanow, C.W. & Isacson, O. (2002a) Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease. Neurosci. Lett., 326, 155-158.
37. McNaught, K.S., Belizaire, R., Isacson, O., Jenner, P. & Olanow, C.W. (2002b) Altered proteasomal function in sporadic Parkinson's disease. Exp. Neurol., in press.
38. McNaught, K.S. & Jenner, P. (2001) Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett., 297, 191-194.
39. McNaught, K.S., Olanow, C.W., Halliwell, B., Isacson, O. & Jenner, P. (2001) Failure of the ubiquitin-proteasome system in Parkinson's disease. Nature Rev. Neurosci., 2, 589-594.
40. Mytilineou, C., Kokotos Leonardi, E.T., Kramer, B.C., Jamindar, T. & Olanow, C.W. (1999) Glial cells mediate toxicity in glutathione-depleted mesencephalic cultures. J. Neurochem., 73, 112-119.
41. Mytilineou, C., Leonardi, E.K., Radcliffe, P., Heinonen, E.H., Han, S.K., Werner, P., Cohen, G. & Olanow, C.W. (1998) Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion. J. Pharmacol. Exp. Ther., 284, 700-706.
42. Pickart, C.M. (2001) Mechanisms underlying ubiquitination. Annu. Rev. Biochem., 70, 503-533.
43. Pollanen, M.S., Dickson, D.W. & Bergeron, C. (1993) Pathology and biology of the Lewy body. J. Neuropathol. Exp. Neurol., 52, 183-191.
44. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E.S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W.G. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 276, 2045-2047.
45. Riley, N.E., Li, J., Worrall, S., Rothnagel, J.A., Swagell, C., van Leeuwen, F.W. & French, S.W. (2002) The Mallory body as an aggresome: In vitro studies. Exp. Mol. Pathol., 72, 17-23.
46. Schapira, A.H., Mann, V.M., Cooper, J.M., Dexter, D., Daniel, S.E., Jenner, P., Clark, J.B. & Marsden, C.D. (1990) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem., 55, 2142-2145.
47. Schlossmacher, M.G., Frosch, M.P., Gai, W.P., Medina, M., Sharma, N., Forno, L., Ochiishi, T., Shimura, H., Sharon, R., Hattori, N., Langston, J.W., Mizuno, Y., Hyman, B.T., Selkoe, D.J. & Kosik, K.S. (2002) Parkin localizes to the lewy bodies of Parkinson disease and dementia with lewy bodies. Am. J. Pathol., 160, 1655-1667.
48. Serrando, M., Casanovas, A. & Esquerda, J.E. (2002) Occurrence of glutamate receptor subunit 1-containing aggresome-like structures during normal development of rat spinal cord interneurons. J. Comp. Neurol., 442, 23-34.
49. Sherman, M.Y. & Goldberg, A.L. (2001) Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases. Neuron, 29, 15-32.
50. Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. & Suzuki, T. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nature Genet., 25, 302-305.
51. Shimura, H., Hattori, N., Kubo, S., Yoshikawa, M., Kitada, T., Matsumine, H., Asakawa, S., Minoshima, S., Yamamura, Y., Shimizu, N. & Mizuno, Y. (1999) Immunohistochemical and subcellular localization of Parkin protein: Absence of protein in autosomal recessive juvenile parkinsonism patients. Ann. Neurol., 45, 668-672.
52. Shimura, H., Schlossmacher, M.G., Hattori, N., Frosch, M.P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K.S. & Selkoe, D.J. (2001) Ubiquitination of a new form of {alpha}-synuclein by parkin from human brain: Implications for Parkinson's disease. Science, 293, 263-269.
53. Shtilerman, M.D., Ding, T.T. & Lansbury, P.T. Jr (2002) Molecular crowding accelerates fibrillization of alpha-synuclein: Could an increase in the cytoplasmic protein concentration induce Parkinson's disease? Biochemistry, 41, 3855-3860.
54. Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M. & Goedert, M. (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl Acad. Sci. USA, 95, 6469-6473.
55. Stearns, T., Evans, L. & Kirschner, M. (1991) Gamma-tubulin is a highly conserved component of the centrosome. Cell, 65, 825-836.
56. Tofaris, G.K., Layfield, R. & Spillantini, M.G. (2001) alpha-Synuclein metabolism and aggregation is linged to ubiqutin-independent degradation by the proteasome. FEBS Lett., 25504, 1-5.
57. Tsirigotis, M., Zhang, M., Chiu, R.K., Wouters, B.G. & Gray, D.A. (2001) Sensitivity of mammalian cells expressing mutant ubiquitin to protein damaging agents. J. Biol. Chem, 276, 46073-46078.
58. Uversky, V.N.E.M.C., Bower, K.S., Li, J. & Fink, A.L. (2002) Accelerated alpha-synuclein fibrillation in crowded milieu. FEBS Lett., 515, 99-103.
59. Voges, D., Zwickl, P. & Baumeister, W. (1999) The 26S proteasome: A molecular machine designed for controlled proteolysis. Annu. Rev. Biochem., 68, 1015-1068.
60. Waelter, S., Boeddrich, A., Lurz, R., Scherzinger, E., Lueder, G., Lehrach, H. & Wanker, E.E. (2001) Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol. Biol. Cell, 12, 1393-1407.
61. Wigley, W.C., Fabunmi, R.P., Lee, M.G., Marino, C.R., Muallem, S., DeMartino, G.N. & Thomas, P.J. (1999) Dynamic association of proteasomal machinery with the centrosome. J. Cell Biol., 145, 481-490.
62. Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E.R. & Mizuno, Y. (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl Acad. Sci. USA, 93, 2696-2701.
63. Zmuda, J.F. & Rivas, R.J. (1998) The Golgi apparatus and the centrosome are localized to the sites of newly emerging axons in cerebellar granule neurons in vitro. Cell Motil. Cytoskeleton, 41, 18-38.